Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study-Reference-Cited by-同舟云学术

Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study

Published:2011-01-07 Issue:3 Volume:25 Page:455-462
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Strahm B, ,Nöllke P,Zecca M,Korthof E T,Bierings M,Furlan I,Sedlacek P,Chybicka A,Schmugge M,Bordon V,Peters C,O'Marcaigh A,de Heredia C D,Bergstraesser E,Moerloose B D,van den Heuvel-Eibrink M M,Starý J,Trebo M,Wojcik D,Niemeyer C M,Locatelli F

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2010297.pdf

Reference29 articles.

1. Niemeyer CM, Kratz CP . Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options. Br J Haematol 2008; 140: 610–624.

2. Hasle H, Wadsworth LD, Massing BG, McBride M, Schultz KR . A population-based study of childhood myelodysplastic syndrome in British Columbia, Canada. Br J Haematol 1999; 106: 1027–1032.

3. Passmore SJ, Chessells JM, Kempski H, Hann IM, Brownbill PA, Stiller CA . Pediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival. Br J Haematol 2003; 121: 758–767.

4. Hasle H, Niemeyer CM, Chessells JM, Baumann I, Bennett JM, Kerndrup G et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 2003; 17: 277–282.

5. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues . IARC Press: Lyon, 2008.

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venetoclax: a new player in the treatment of children with high-risk myeloid malignancies?;Blood Advances;2024-07-09

2. Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation?;HemaSphere;2024-07

3. The different faces of GATA2 deficiency: implications for therapy and surveillance;Frontiers in Oncology;2024-06-27

4. Decitabine-containing conditioning improved outcomes for children with higher-risk myelodysplastic syndrome undergoing allogeneic hematopoietic stem cell transplantation;Annals of Hematology;2024-02-06

5. The role of genetic factors in pediatric myelodysplastic syndromes with different outcomes;BMC Pediatrics;2024-01-08